Global Prostate Cancer Medicine Market Research Report 2017

October 2017 | 104 pages | ID: GC8C1CC51FFEN
QYResearch

Abstracts

In this report, the global Prostate Cancer Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Prostate Cancer Medicine in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Prostate Cancer Medicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• AstraZeneca plc
• Active Biotech
• Bristol Myers-Squibb
• Teva Pharmaceuticals Industries Ltd.
• Johnson & Johnson
• Pfizer Inc.
• Bayer AG
• Abbott Laboratories
• Astellas Pharma Inc.
• Roche Holding AG

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Hormonal Therapy Drugs
• Chemotherapy Drugs
• Immunotherapy Drugs
• Target Therapy Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Prostate Cancer Medicine for each application, including

• Hospital
• Pharmacy
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Prostate Cancer Medicine Market Research Report 2017

1 PROSTATE CANCER MEDICINE MARKET OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Medicine
1.2 Prostate Cancer Medicine Segment by Type (Product Category)
  1.2.1 Global Prostate Cancer Medicine Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Prostate Cancer Medicine Production Market Share by Type (Product Category) in 2016
  1.2.3 Hormonal Therapy Drugs
  1.2.4 Chemotherapy Drugs
  1.2.5 Immunotherapy Drugs
  1.2.6 Target Therapy Drugs
1.3 Global Prostate Cancer Medicine Segment by Application
  1.3.1 Prostate Cancer Medicine Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Others
1.4 Global Prostate Cancer Medicine Market by Region (2012-2022)
  1.4.1 Global Prostate Cancer Medicine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Prostate Cancer Medicine (2012-2022)
  1.5.1 Global Prostate Cancer Medicine Revenue Status and Outlook (2012-2022)
  1.5.2 Global Prostate Cancer Medicine Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL PROSTATE CANCER MEDICINE MARKET COMPETITION BY MANUFACTURERS

2.1 Global Prostate Cancer Medicine Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Prostate Cancer Medicine Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Prostate Cancer Medicine Production and Share by Manufacturers (2012-2017)
2.2 Global Prostate Cancer Medicine Revenue and Share by Manufacturers (2012-2017)
2.3 Global Prostate Cancer Medicine Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Prostate Cancer Medicine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Prostate Cancer Medicine Market Competitive Situation and Trends
  2.5.1 Prostate Cancer Medicine Market Concentration Rate
  2.5.2 Prostate Cancer Medicine Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PROSTATE CANCER MEDICINE CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Prostate Cancer Medicine Capacity and Market Share by Region (2012-2017)
3.2 Global Prostate Cancer Medicine Production and Market Share by Region (2012-2017)
3.3 Global Prostate Cancer Medicine Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL PROSTATE CANCER MEDICINE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Prostate Cancer Medicine Consumption by Region (2012-2017)
4.2 North America Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
4.3 Europe Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
4.4 China Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
4.5 Japan Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)
4.7 India Prostate Cancer Medicine Production, Consumption, Export, Import (2012-2017)

5 GLOBAL PROSTATE CANCER MEDICINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Prostate Cancer Medicine Production and Market Share by Type (2012-2017)
5.2 Global Prostate Cancer Medicine Revenue and Market Share by Type (2012-2017)
5.3 Global Prostate Cancer Medicine Price by Type (2012-2017)
5.4 Global Prostate Cancer Medicine Production Growth by Type (2012-2017)

6 GLOBAL PROSTATE CANCER MEDICINE MARKET ANALYSIS BY APPLICATION

6.1 Global Prostate Cancer Medicine Consumption and Market Share by Application (2012-2017)
6.2 Global Prostate Cancer Medicine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PROSTATE CANCER MEDICINE MANUFACTURERS PROFILES/ANALYSIS

7.1 AstraZeneca plc
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 AstraZeneca plc Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Active Biotech
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Active Biotech Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Bristol Myers-Squibb
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Teva Pharmaceuticals Industries Ltd.
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Johnson & Johnson
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Johnson & Johnson Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Pfizer Inc.
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Pfizer Inc. Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Bayer AG
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Bayer AG Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Abbott Laboratories
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Abbott Laboratories Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Astellas Pharma Inc.
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Roche Holding AG
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Prostate Cancer Medicine Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Roche Holding AG Prostate Cancer Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview

8 PROSTATE CANCER MEDICINE MANUFACTURING COST ANALYSIS

8.1 Prostate Cancer Medicine Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Prostate Cancer Medicine

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Prostate Cancer Medicine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Prostate Cancer Medicine Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PROSTATE CANCER MEDICINE MARKET FORECAST (2017-2022)

12.1 Global Prostate Cancer Medicine Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Prostate Cancer Medicine Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Prostate Cancer Medicine Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Prostate Cancer Medicine Price and Trend Forecast (2017-2022)
12.2 Global Prostate Cancer Medicine Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Prostate Cancer Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Prostate Cancer Medicine Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Prostate Cancer Medicine Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Medicine
Figure Global Prostate Cancer Medicine Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Prostate Cancer Medicine Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Hormonal Therapy Drugs
Table Major Manufacturers of Hormonal Therapy Drugs
Figure Product Picture of Chemotherapy Drugs
Table Major Manufacturers of Chemotherapy Drugs
Figure Product Picture of Immunotherapy Drugs
Table Major Manufacturers of Immunotherapy Drugs
Figure Product Picture of Target Therapy Drugs
Table Major Manufacturers of Target Therapy Drugs
Figure Global Prostate Cancer Medicine Consumption (K Units) by Applications (2012-2022)
Figure Global Prostate Cancer Medicine Consumption Market Share by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Prostate Cancer Medicine Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Prostate Cancer Medicine Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Prostate Cancer Medicine Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Prostate Cancer Medicine Major Players Product Capacity (K Units) (2012-2017)
Table Global Prostate Cancer Medicine Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Prostate Cancer Medicine Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Prostate Cancer Medicine Capacity (K Units) of Key Manufacturers in 2016
Figure Global Prostate Cancer Medicine Capacity (K Units) of Key Manufacturers in 2017
Figure Global Prostate Cancer Medicine Major Players Product Production (K Units) (2012-2017)
Table Global Prostate Cancer Medicine Production (K Units) of Key Manufacturers (2012-2017)
Table Global Prostate Cancer Medicine Production Share by Manufacturers (2012-2017)
Figure 2016 Prostate Cancer Medicine Production Share by Manufacturers
Figure 2017 Prostate Cancer Medicine Production Share by Manufacturers
Figure Global Prostate Cancer Medicine Major Players Product Revenue (Million USD) (2012-2017)
Table Global Prostate Cancer Medicine Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Prostate Cancer Medicine Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Prostate Cancer Medicine Revenue Share by Manufacturers
Table 2017 Global Prostate Cancer Medicine Revenue Share by Manufacturers
Table Global Market Prostate Cancer Medicine Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Prostate Cancer Medicine Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Prostate Cancer Medicine Manufacturing Base Distribution and Sales Area
Table Manufacturers Prostate Cancer Medicine Product Category
Figure Prostate Cancer Medicine Market Share of Top 3 Manufacturers
Figure Prostate Cancer Medicine Market Share of Top 5 Manufacturers
Table Global Prostate Cancer Medicine Capacity (K Units) by Region (2012-2017)
Figure Global Prostate Cancer Medicine Capacity Market Share by Region (2012-2017)
Figure Global Prostate Cancer Medicine Capacity Market Share by Region (2012-2017)
Figure 2016 Global Prostate Cancer Medicine Capacity Market Share by Region
Table Global Prostate Cancer Medicine Production by Region (2012-2017)
Figure Global Prostate Cancer Medicine Production (K Units) by Region (2012-2017)
Figure Global Prostate Cancer Medicine Production Market Share by Region (2012-2017)
Figure 2016 Global Prostate Cancer Medicine Production Market Share by Region
Table Global Prostate Cancer Medicine Revenue (Million USD) by Region (2012-2017)
Table Global Prostate Cancer Medicine Revenue Market Share by Region (2012-2017)
Figure Global Prostate Cancer Medicine Revenue Market Share by Region (2012-2017)
Table 2016 Global Prostate Cancer Medicine Revenue Market Share by Region
Figure Global Prostate Cancer Medicine Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Prostate Cancer Medicine Consumption (K Units) Market by Region (2012-2017)
Table Global Prostate Cancer Medicine Consumption Market Share by Region (2012-2017)
Figure Global Prostate Cancer Medicine Consumption Market Share by Region (2012-2017)
Figure 2016 Global Prostate Cancer Medicine Consumption (K Units) Market Share by Region
Table North America Prostate Cancer Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Prostate Cancer Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Prostate Cancer Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Prostate Cancer Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Prostate Cancer Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Prostate Cancer Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Prostate Cancer Medicine Production (K Units) by Type (2012-2017)
Table Global Prostate Cancer Medicine Production Share by Type (2012-2017)
Figure Production Market Share of Prostate Cancer Medicine by Type (2012-2017)
Figure 2016 Production Market Share of Prostate Cancer Medicine by Type
Table Global Prostate Cancer Medicine Revenue (Million USD) by Type (2012-2017)
Table Global Prostate Cancer Medicine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Prostate Cancer Medicine by Type (2012-2017)
Figure 2016 Revenue Market Share of Prostate Cancer Medicine by Type
Table Global Prostate Cancer Medicine Price (USD/Unit) by Type (2012-2017)
Figure Global Prostate Cancer Medicine Production Growth by Type (2012-2017)
Table Global Prostate Cancer Medicine Consumption (K Units) by Application (2012-2017)
Table Global Prostate Cancer Medicine Consumption Market Share by Application (2012-2017)
Figure Global Prostate Cancer Medicine Consumption Market Share by Applications (2012-2017)
Figure Global Prostate Cancer Medicine Consumption Market Share by Application in 2016
Table Global Prostate Cancer Medicine Consumption Growth Rate by Application (2012-2017)
Figure Global Prostate Cancer Medicine Consumption Growth Rate by Application (2012-2017)
Table AstraZeneca plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca plc Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca plc Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure AstraZeneca plc Prostate Cancer Medicine Production Market Share (2012-2017)
Figure AstraZeneca plc Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Active Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Active Biotech Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Active Biotech Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure Active Biotech Prostate Cancer Medicine Production Market Share (2012-2017)
Figure Active Biotech Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Bristol Myers-Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol Myers-Squibb Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Production Market Share (2012-2017)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Teva Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Production Market Share (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure Johnson & Johnson Prostate Cancer Medicine Production Market Share (2012-2017)
Figure Johnson & Johnson Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc. Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure Pfizer Inc. Prostate Cancer Medicine Production Market Share (2012-2017)
Figure Pfizer Inc. Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure Bayer AG Prostate Cancer Medicine Production Market Share (2012-2017)
Figure Bayer AG Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure Abbott Laboratories Prostate Cancer Medicine Production Market Share (2012-2017)
Figure Abbott Laboratories Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Inc. Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Production Market Share (2012-2017)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Roche Holding AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Holding AG Prostate Cancer Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Holding AG Prostate Cancer Medicine Production Growth Rate (2012-2017)
Figure Roche Holding AG Prostate Cancer Medicine Production Market Share (2012-2017)
Figure Roche Holding AG Prostate Cancer Medicine Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Medicine
Figure Manufacturing Process Analysis of Prostate Cancer Medicine
Figure Prostate Cancer Medicine Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Medicine Major Manufacturers in 2016
Table Major Buyers of Prostate Cancer Medicine
Table Distributors/Traders List
Figure Global Prostate Cancer Medicine Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Prostate Cancer Medicine Price (Million USD) and Trend Forecast (2017-2022)
Table Global Prostate Cancer Medicine Production (K Units) Forecast by Region (2017-2022)
Figure Global Prostate Cancer Medicine Production Market Share Forecast by Region (2017-2022)
Table Global Prostate Cancer Medicine Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Prostate Cancer Medicine Consumption Market Share Forecast by Region (2017-2022)
Figure North America Prostate Cancer Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Prostate Cancer Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Prostate Cancer Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Prostate Cancer Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Prostate Cancer Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Prostate Cancer Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Prostate Cancer Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Prostate Cancer Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Prostate Cancer Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Prostate Cancer Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Prostate Cancer Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Prostate Cancer Medicine Production (K Units) Forecast by Type (2017-2022)
Figure Global Prostate Cancer Medicine Production (K Units) Forecast by Type (2017-2022)
Table Global Prostate Cancer Medicine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Prostate Cancer Medicine Revenue Market Share Forecast by Type (2017-2022)
Table Global Prostate Cancer Medicine Price Forecast by Type (2017-2022)
Table Global Prostate Cancer Medicine Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Prostate Cancer Medicine Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source